Join AAN in advocating for neuroscience research and telehealth provisions during the 2026 'Neurology on the Hill' event. Secure the future of neurological care access!

Study reveals geographic and sociodemographic factors driving epilepsy incidence among older U.S. adults, highlighting regional disparities and associated risk factors.

The FDA has approved Lumipulse, the first blood test for Alzheimer's diagnosis in symptomatic older adults, enabling less invasive detection of amyloid plaques and supporting earlier, accurate diagnosis and treatment options.